Monoamine metabolism and depression in Parkinson patients.
D003863:Depression / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D011339:Probenecid; D012701:Serotonin / Q000378:metabolism*
D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D011339:Probenecid; D006719:Homovanillic Acid